Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5281929
Chembl Id: CHEMBL5281929
Max Phase: Preclinical
Molecular Formula: C33H46N6O5S
Molecular Weight: 638.84
Associated Items:
ID: ALA5281929
Chembl Id: CHEMBL5281929
Max Phase: Preclinical
Molecular Formula: C33H46N6O5S
Molecular Weight: 638.84
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCCC3)nc3[nH]cnc23)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C33H46N6O5S/c1-6-31(4)15-22(32(5)19(2)9-11-33(20(3)27(31)43)12-10-21(40)26(32)33)44-24(42)17-45-29-25-28(35-18-34-25)37-30(38-29)36-23(41)16-39-13-7-8-14-39/h6,18-20,22,26-27,43H,1,7-17H2,2-5H3,(H2,34,35,36,37,38,41)/t19-,20+,22-,26?,27+,31-,32+,33+/m1/s1
Standard InChI Key: YHSWFTTXDQMULP-RKPWQCSBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 638.84 | Molecular Weight (Monoisotopic): 638.3250 | AlogP: 4.39 | #Rotatable Bonds: 8 |
Polar Surface Area: 150.40 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.65 | CX Basic pKa: 6.79 | CX LogP: 3.95 | CX LogD: 3.61 |
Aromatic Rings: 2 | Heavy Atoms: 45 | QED Weighted: 0.16 | Np Likeness Score: 0.53 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):